Poor nutritional status and increased severity of pneumonia were associated with higher mortality rates among patients with aspiration pneumonia, according to a recent study. “Aspiration pneumonia is ...

European medical officials advised patients taking GLP-1 weight loss and diabetes drugs who will be sedated for an upcoming surgery to warn their doctors about their medication use to avoid the risk ...

A simple sip of water can turn life-threatening, leading to aspiration pneumonia when liquid enters the lungs instead of the stomach. This condition, often caused by bacteria in aspirated material, ...

The use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may lead to an increased risk for aspiration pneumonia after endoscopic procedures, according to a new large population-based study. In ...

Compared with 0.63% of non-users, 0.83% patients on a GLP-1 receptor agonist experienced aspiration pneumonia within a month of the procedure, Kevin Sheng-Kai Ma, DDS, of Brigham and Women's Hospital ...

Please provide your email address to receive an email when new articles are posted on . Glucagon-like peptide-1 receptor agonists were associated with a higher risk for aspiration pneumonia after ...

New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.

However, delayed gastric emptying could theoretically increase the risk for pulmonary aspiration during general anesthesia or deep sedation, a risk that the EMA described as "biologically plausible." ...

Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. There was also no significant difference in the odds of acute respiratory failure.